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Abstract CRISPR-associated (Cas) nucleases are
established tools for engineering of animal genomes.
These programmable RNA-guided nucleases have
been introduced into zygotes using expression vectors,
mRNA, or directly as ribonucleoprotein (RNP) com-
plexes by different delivery methods. Whereas
microinjection techniques are well established, more
recently developed electroporation methods simplify
RNP delivery but can provide less consistent effi-
ciency. Previously, we have designed Cas12a-crRNA
pairs to introduce large genomic deletions in theUbn1,
Ubn2, and Rbm12 genes in mouse embryonic stem
cells (ESC). Here, we have optimized the conditions
for electroporation of the same Cas12a RNP pairs into
mouse zygotes. Using our protocol, large genomic
deletions can be generated efficiently by electropora-
tion of zygotes with or without an intact zona
pellucida. Electroporation of as few as ten zygotes is
sufficient to obtain a gene deletion in mice suggesting
potential applicability of this method for species with
limited availability of zygotes.
Keywords CRISPR-Cas  Cas12a  Cpf1 
Electroporation  Mutation  Mouse embryo  Gene
deletion
Introduction
Clustered regularly interspaced short palindromic
repeat (CRISPR) associated nucleases are components
of bacterial and archaeal adaptive defense mecha-
nisms against invasive nucleic acids such as plasmids
or viral DNA (Horvath and Barrangou 2010). These
nuclease enzymes associate with short CRISPR RNAs
(crRNA) that guide them to complementary target
sequences in the genome. As the CRISPR associated
nucleases Cas9 and Cas12a can be programmed with
crRNA sequences of choice, they have been repur-
posed into a versatile genome editing tool for many
Electronic supplementary material The online version of
this article (https://doi.org/10.1007/s11248-019-00168-9) con-
tains supplementary material, which is available to authorized
users.
C.-E. Dumeau (&)  A. Monfort  L. Kissling 
A. Wutz (&)
Department of Biology, Institute of Molecular Health
Sciences, Swiss Federal Institute of Technology, Zurich,
Switzerland
e-mail: charles-etienne.dumeau@biol.ethz.ch
A. Wutz
e-mail: awutz@ethz.ch
L. Kissling  D. C. Swarts  M. Jinek
Department of Biochemistry, University of Zurich,
Zurich, Switzerland
Present Address:
D. C. Swarts
Laboratory of Biochemistry, Department of Agrotechnology
and Food Sciences, Wageningen University, 6708 WE Wa-
geningen, The Netherlands
123
Transgenic Res (2019) 28:525–535
https://doi.org/10.1007/s11248-019-00168-9(0123456789().,-volV)( 0123456789().,-volV)
biological tissues in different species (Hai et al. 2014;
Hwang et al. 2013; Jinek et al. 2012; Lee et al. 2019;
Mali et al. 2013; Sung et al. 2014; Wang et al. 2013).
During genome editing, both Cas9 and Cas12a gen-
erate DNA double strand breaks (DSB) at sequences
that are complementary to the crRNA sequence (Dong
et al. 2016; Fonfara et al. 2016; Jinek et al. 2012;
Zetsche et al. 2015), which subsequently trigger
cellular DNA repair processes. Two distinct cellular
DNA repair mechanisms are known: Homology
directed repair (HDR) requires a template and can be
used to engineer precise genomic mutations, whereas
non-homologous end joining (NHEJ) generates small
insertions or deletions (indels) at the site of the break
(Cong et al. 2013; Jinek et al. 2013; Mali et al. 2013).
Cas9 has been exploited in combination with both
repair mechanisms for developing highly efficient
methods for producing genomic mutations in mice
(Hai et al. 2014; Sung et al. 2014; Wang et al. 2013).
Using Cas9 nucleases in combination with targeting
vectors has further facilitated gene targeting in mouse
zygotes by pronuclear microinjection (Wang et al.
2015). Recently, it could be demonstrated that
microinjection of Cas9-crRNA RNP complexes can
increase the efficiency of gene targeting in mouse
zygotes (Jung et al. 2017). These studies suggest that
ESC technology might be replaced by direct engi-
neering of the zygotic genome for gene targeting.
Nevertheless, microinjection techniques take con-
siderable time to perform and require extensive
training for obtaining high rates of transgenesis and
embryo survival. To overcome these difficulties,
square wave electroporation techniques have been
developed to introduce Cas9 mRNA/crRNA or Cas9-
RNP complexes into mouse and rat zygotes using
different electroporation systems (Hashimoto et al.
2016; Kaneko andMashimo 2015; Kaneko et al. 2014;
Qin et al. 2015; Troder et al. 2018). Zygote electro-
poration requires establishing suitable parameters that
facilitate uptake of Cas9 but also limit damage to the
embryo. A first poring pulse series is applied to
permeabilize the zona pellucida and the cell mem-
brane of the zygote. Subsequently, a second transfer
pulse series delivers the Cas9 mRNA/crRNA or the
Cas9-RNP complex into the cytoplasm (Hashimoto
and Takemoto 2015; Hashimoto et al. 2016). Further
refinement of zygote electroporation has focused on
poring pulse parameters for optimizing RNP delivery
and zygote survival (Modzelewski et al. 2018).
Although zygote electroporation requires skills for
embryo handling, microinjection skills are dispens-
able, making this technique accessible to a broad range
of scientists.
More recently, also Cas12a-RNP complexes have
been used for generating indel mutations by electro-
poration into zygotes (Hur et al. 2016). Cas12a also
generates DSB but has divergent characteristics com-
pared to Cas9 including differences in crRNA binding,
DNA recognition, and DNA cleavage mechanism,
which expands the genome editing tool box (Swarts
and Jinek 2018). Cas12a nucleases are guided to
specific DNA sequences by crRNAs which are 40–44
nucleotides long and can easily be obtained by
chemical synthesis. In contrast, Cas9 nucleases are
guided by longer sgRNAs (* 101 nucleotides) or by
dual-RNA consisting of a separate tracrRNA (* 75
nucleotides) and crRNA (39–42 nucleotides) (Kaneko
and Mashimo 2015; Modzelewski et al. 2018; Swarts
and Jinek 2018). The use of chemically synthesized
crRNAs, which can be obtained at high purity,
guaranteed length, and exact sequence, make exper-
imental planning easier and provide reagents of a
standardized quality for experiments involving ani-
mals. Shorter RNAs can be more cost effective to
synthesize suggesting that Cas12a nucleases might
have advantages over Cas9 nucleases for genetic
engineering of ESCs or zygotes by RNP electropora-
tion. While the molecular mechanisms of Cas12a
nucleases have been extensively characterized (Dong
et al. 2016; Fonfara et al. 2016; Zetsche et al. 2015),
in vivo applications of Cas12a remain less well
established compared to in vivo applications of
Cas9. In a previous study, we have provided a protocol
for generating large deletions in mouse ESCs by
electroporation of Cas12a RNP complexes (Kissling
et al. 2019). For this, two CRISPR-Cas nucleases are
designed that cleave the genome at separated sites
within a gene locus such that loss of the intervening
sequence will result in a deletion. Large genomic
deletions are advantageous for mutation of genes for
which critical domains are unknown or for which
specific antisera are not available. Removal of a large
segment of the gene locus increases the probability for
generating a strong and likely complete loss-of-
function mutation. Small deletions including frame
shift mutations afford less certainty about residual
gene function, especially when alternative splicing
needs to be considered. In our previous study, we
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identified pairs of crRNAs for efficient engineering of
Cas12a-RNP complex-mediated 10 kilobasepair (kb),
17 kb, and 13 kb long genomic deletions within the
Ubinuclein 1 (Ubn1), Ubinuclein 2 (Ubn2), and RNA
binding motif protein 12 (Rbm12) genes, respectively.
Here, we extend our earlier study in mouse ESCs to
engineer large genomic deletions in mouse zygotes
through electroporation of Cas12a-RNP complexes.
Materials and methods
Zygote production and partial zona removal
For obtaining zygotes, 6–8-week-old Crl:CD1(ICR)
females were superovulated and mated to
Crl:CD1(ICR) males the night before zygote collec-
tion. Pregnant Mare Serum Gonadotropin (PMSG,
Avivasysbio cat. no. OPPA1037 5000 IU) and human
Chorionic Gonadotropin (hCG, MSD animal health
Chorulon 5000, Swissmedic cat. no. 49451) were
diluted in PBS at 50 IU/ml and stored at - 20 C in
1 ml aliquots. 5 IU PMSG, and hCG were adminis-
tered per mouse by intraperitoneal injection using 27G
hypodermic needles 66 and 19 h before collection,
respectively. Zygotes were isolated from the ampulla
of dissected oviducts in M2 medium (Sigma, cat. no.
M7167). Cumulus masses were treated with hyalur-
onidase (Sigma cat. no. H4272) at 0.5 mg/ml in M2
medium, washed 3 times in M2 medium, and
incubated at 37 C, 5% CO2 in 60 mm center well
culture dishes (Corning Incorporated, Costar cat. no.
3260) in KSOM medium (Millipore Embryomax cat.
no. MR-020P-5F) supplemented with 1% NEAA
(NEAA 100X Gibco, cat. no. 11140035) before
electroporation. Zygotes with abnormal morphology
were discarded after visual inspection. For partial
removal of the zona pellucida zygotes were treated
with acidic Tyrode’s solution (Sigma, cat. no. T1788)
for 20–30 s under a stereomicroscope to follow the
thinning of the zona, washed 3 times in M2 medium
and used for electroporation (AT group). Glass
pipettes for handling zygotes and embryos were hand
drawn over a flame from Hirschmann 100 ll micro-
pipettes (Sigma cat. no. Z61163). All animal exper-
iments were carried out in compliance with cantonal
and federal animal welfare regulations.
Cas12a nuclease RNP assembly
Production of the Cas12a-NLS-NLS-eGFP-NLS
fusion protein (Cas12a nuclease), design of crRNAs,
verification of DNA cleavage activity in vitro and PCR
analysis of genomic deletions in Ubn1, Ubn2, and
Rbm12 were previously described (Kissling et al.
2019). crRNA sequences are listed (Suppl. Table 2).
The Cas12a nuclease protein was stored as a 12 lM
stock solution in SEC buffer (20 mM HEPES pH 7.5,
500 mM KCl, 1 mM DTT) at - 80 C. For engineer-
ing deletions, pairs of Cas12a RNPs were used for
electroporation. The two RNP complexes were assem-
bled separately. For RNP complex assembly (15 ll
total volume) 8.3 ll Cas12a protein (12 lM) in SEC
buffer, 1.5 ll crRNA (100 lM) in ddH2O, and 5.2 ll
of Cas12a buffer (Tris-HCl 8 mM pH7.4, EDTA
0.1 mM, MgCl2 2 mM) were mixed in an Eppendorf
tube. The final concentrations for Cas12a protein, and
crRNA were 6.64 lM, and 10 lM, respectively.
Assembly was carried out by incubation for 10 min
at room temperature. Thereafter RNP complexes were
stored at 4 C until use for electroporation. RNP
complexes that were stored over night maintained
activity. The two independently assembled RNP
complexes were mixed in a 1:1 ratio (30 ll final
volume) before electroporation and kept on ice.
Zygote electroporation
Electroporations were carried out with a NEPA21 type
II electroporator (Nepagene), a 5 ll electrode chamber
with a gap width of 1 mm (Nepagene CUY501P1-
1.5), and connection cables (Nepagene C115CB, and
C117). The instrument was operated following the
instructions of the manufacturer and used with the
settings listed in Table 1. The electrode chamber was
filled with 5 ll of Cas12a nuclease pair mix. Zygotes
(up to 40) were washed through 3 micro-drops of RNP
mix and transferred into the electrode chamber by
mouth pipetting. The sample impedance was mea-
sured on the NEPA21 instrument and adjusted to a
value within the range from 190 and 200 Ohm by
adding or removing RNP mix. After electroporation
zygotes were transferred into center well culture
dishes with KSOM medium supplemented with 1%
NEAA.
123
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Derivation of ESC lines
Mouse embryos were cultured in KSOM medium
supplemented with 1% NEAA to the 8-cell stage and
then transferred into KSOM media (Millipore Embry-
omax cat. no. MR-020P-5F) supplemented with 1%
NEAA, 2% Essential amino-acid (EAA 50X Gibco,
cat. no.11130051), 1 mg/ml glucose, 1 lM
PDO325901, and 3 lM CHIR99021 until they
reached the late blastocyst stage. Inner cell masses
were isolated by immunosurgery (Solter and Knowles
1975), and cultured in N2B27?2i/LIF medium for
feeder free ESC derivation as previously published
(Nichols et al. 2009a, b).
Genotyping by PCR
ESC lines were genotyped by PCR reactions using
primer pairs spanning the deletion, and flanking the
cleavage sites as previously published (Kissling et al.
2019). A PCR master mix was prepared on ice for the
number of samples tested. One PCR reaction is
composed of 16.1 ll ddH2O, 2 ll Thermopol Buffer
(NEB), 0.4 ll 10 mM dNTP mix, 0.4 ll 10 lM
forward primer, 0.4 ll 10 lM reverse primer, 0.1 ll
TAQ polymerase (NEB M0267 at 5000U/ml) and
0.6 ll DNA template. Thermocycler programs were
setup following the guidelines of the supplier (NEB).
Primer sequences and pairs are provided in Suppl.
Tables 3 and 4 with corresponding annealing
temperatures.
Results
The NEPA electroporation system has been previously
used for zygote electroporation (Hashimoto and
Takemoto 2015; Hashimoto et al. 2016; Hur et al.
2016) and is available with electroporation chambers
that are specifically designed for use with embryos.
We adopted a workflow for electroporation of CD1
zygotes with an equimolar mix of two Cas12a RNPs
for inducing genomic deletions within genes. After
electroporation we cultured embryos in vitro to the
blastocyst stage to derive ESC lines that represent
clonal populations where genotyping of the genetic
modifications can be performed by PCR (Fig. 1a). The
setup for electroporation requires a mouth pipette, a
stereomicroscope for embryo handling, and the
NEPA21 electroporator (Fig. 1b). The NEPA electro-
poration system enables measurements of sample
conductance and a precise reading of electrical
intensity and energy delivered, which improves the
reproducibility of the experimental conditions. Previ-
ous studies have reported electroporation into zygotes
in a volume of 100 ll (Hur et al. 2016; Kaneko and
Mashimo 2015; Kaneko et al. 2014) using an electrode
chambers with an electrode gap of 5 mm. More
recently a 5 ll chamber with an electrode gap of 1 mm
has become available reducing the reagent volume. An
earlier study has successfully used such a chamber for
electroporation of Cas9 nucleases into mouse zygotes
(Teixeira et al. 2018). We decided to test this
electroporation chamber for electroporation of Cas12a
nucleases (Fig. 1c, d). Initially, we evaluated the
effect of poring pulse voltage with a constant poring
pulse number of 4 on embryo survival (Suppl. Fig. 1,
and Suppl. Table 1). With a poring pulse of 30 V
embryo survival approached 100%, while 40 and 50 V
poring pulses gave also high embryo survival rates (on
average 90% and 84%, respectively). However, we did
not detect successful Cas12a-RNP complex-mediated
deletions with these series of 4 pulses. We therefore
increased the number of pulses and the interval
between pulses. Trials with adjusted poring pulse
voltage of 45 V over 1 mm electrode gap width, which
corresponds to the same electrical field strength as the
original conditions using 225 V over a 5 mm elec-
trode gap, resulted in substantial lysis of zygotes and
caused loss of embryos (data not shown). We did not
further pursue experiments with higher voltages and
selected 30 V as the highest voltage that was compat-
ible with zygote survival in our preliminary experi-
ments. Using 6 poring pulses of 30 V, 3 ms length
(Modzelewski et al. 2018), 100 ms intervals, 10%
decay rate, and positive (?) polarity followed by 5
transfer pulses of 5 V, 50 ms length, 50 ms interval,
40% decay rate, and alternating (?/-) polarity we
successfully detected Cas12a-RNP complex-mediated
deletion with little or no loss of embryos (data not
shown).
To assess the reproducibility of small volume
zygote electroporation, we aimed at generating dele-
tions in three genes, Ubn1, Ubn2, and Rmb12. For
these genes no mutations have been described in mice
to date, and we have identified efficient Cas12a-
crRNA combinations in mouse ESC electroporation
experiments in a previous study (Kissling et al. 2019).
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Although a large number of Cas12a-crRNA combi-
nations showed excellent cleavage of their DNA
targets in vitro, only a subset of Cas12a-crRNA RNPs
yielded efficient deletions in ESCs. This discrepancy
was not trivially explained by sequence context or
local chromatin accessibility as nucleases targeting
opposite strands in close proximity showed substantial
differences as evidenced by assessing NHEJmutations
(Kissling et al. 2019). This suggests that combinations
of the accessibility, sequence preference, and repair
processes might influence the effective rates in cellular
systems with which deletions can be obtained.
Empirical determination of cleavage and deletion
a
electroporation
embryo culture
ES cell derivation
Detection of deletions
by PCR
CD1 zygotes from
superovulated
donor females
Mix of two
(Cas12a + crRNA)
b
d
c
Fig. 1 Experimental setup
and overview of the
procedure for zygote
electroporation.
a Scheme of the
experimental strategy for
engineering gene deletions
by zygote electroporation.
Scale bar, 200 lm. b Setup
of the work area for zygote
electroporation and
placement of a NEPA21
electroporation system and
stereomicroscope.
c Picture of the
electroporation chamber
used for electroporation in
5 ll volume and electrical
connections. d Placement of
mouse zygotes between the
electrodes just prior to
electroporation using a
handling pipette under the
stereomicroscope. Scale bar,
1 mm
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efficiency is therefore a prerequisite for testing the
methodology for zygote genetic engineering.
We used the same Cas12a-crRNA RNPs for small
volume zygote electroporation in this study. A total of
251 zygotes were collected for electroporation. For
each experiment we divided the zygotes into two
groups. The first group of zygotes was treated with
acidic Tyrod’s solution (AT) for 20–30 s to partially
remove the zona pellucida. The second group of
zygotes was used for electroporation with an intact
zona pellucida (NoAT). Thirty minutes after electro-
poration we monitored embryo lysis by inspection
under the microscope. The overall survival rates were
85%, and 92% for the NoAT and AT groups,
respectively (Table 2). Subsequently, zygotes were
cultured in vitro and their development was followed
through inspection under a stereomicroscope. For the
NoAT and AT groups 98% and 95% of the embryos
reached the 2 cell-stage, 68% and 62% developed into
morulae, and 37% and 36% to blastocysts, respec-
tively (Table 2). To obtain clonal cell populations for
analysis of genetic modifications, we subsequently
derived 30 ESC lines from blastocysts for each group
Table 1 Settings of the NEPA21 electroporation system for zygote electroporation using a 5 ll electrode chamber
Voltage (V) Length (ms) Interval (ms) Number of pulses D. Rate (%) Polarity
Poring pulse 30 3 100 6 10 ?
Transfer pulse 5 50 50 5 40 ? / -
cFig. 2 Schematic representation of the strategies for engineer-
ing deletions in the Ubn1, Ubn2, and Rbm12 genes. The
structure of the gene locus is shown along with the locations of
crRNAs (red full arrows), predicted cleavage sites (dashed red
arrows), and PCR primers (black arrows) for a Ubn1, b Ubn2,
and c Rbm12. (Color figure online)
Table 2 Survival and in vitro development of mouse embryos after electroporation of zygotes with either intact or partially removed
zona pellucida with acidic Tyrode’s solution (AT)
Gene Zygotes AT Survivala 2-Cellb Morulab Blastocystb ESC linesb Deletionc Inversionc
Ubn1 47 No 47
100%
45
96%
23
49%
10
21%
10
21%
6
60%
1
10%
Ubn2 39 No 28
72%
28
100%
27
96%
13
46%
7
25%
3
43%
0
0%
Rbm12 40 No 32
80%
32
100%
23
72%
17
53%
13
41%
3
23%
3
23%
Total 126 No 107
85%
105
98%
73
68%
40
37%
30
28%
12
40%
4
13%
Ubn1 50 Yes 50
100%
45
90%
23
46%
13
26%
13
26%
7
54%
1
8%
Ubn2 38 Yes 32
84%
32
100%
30
94%
13
41%
11
34%
7
64%
0
0%
Rbm12 37 Yes 33
89%
32
97%
18
55%
15
45%
6
18%
1
17%
1
17%
Total 125 Yes 115
92%
109
95%
71
62%
41
36%
30
26%
15
50%
2
7%
aPercentages are based on the number of zygotes that were used for electroporation
bPercentages are based on the number of zygotes that survived electroporation
cPercentages are based on the number of ES cell lines that were derived
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with a derivation rate of 28% and 26% for the NoAT
and AT group, respectively (Table 2). Since ESC lines
are derived from individual epiblast cells the genotype
can be directly assessed. In contrast, analysis of
embryos can be more difficult as cells of heteroge-
neous allelic constitution can result from Cas12a
nuclease induced cleavage after DNA replication or in
cleavage stage embryos. Analysis of resulting chi-
meric embryos is complicated by the existence of cells
with potentially divergent genotypes. This problem is
avoided by analyzing clonal ESC populations.
The presence or absence of genomic deletions was
detected by PCR using primer pairs that flank the
genomic positions of the Cas12a cleavage sites
(Fig. 2a–c). We tested the samples as well for the
presence of wild-type sequence spanning both cleav-
age sites (Fig. 2a–c referred to as PCR1 and PCR2 for
the in 50 and 30 flanking region, respectively). Finally
we looked for sequence inversion by inverting the
primer pair combination of PCR1 and PCR2. We
observed frequencies of gene deletions ranging from
17 to 64% with an overall frequency of deletion of
40% and 50% for the NoAT an AT group, respectively
(Fig. 3a–c and Table 2). There was a considerable
variation in the deletion frequency between the genes.
The lowest frequency of deletions was observed for
the Rbm12 gene with 23% and 17% of ESC lines
carrying deletions for the NoAT and AT group,
respectively. The highest deletion frequencies were
observed for Ubn1 in the NoAT group with 60%, and
for Ubn2 in the AT group with 64% of ESC lines
carrying deletions. We further characterized several
deletions by sequencing of PCR products (Suppl.
Fig. 2). We also detected sequence inversion forUbn1
and Rbm12 with an overall frequency of 13% and 7%
for the NoAT and AT group, respectively. Taken
together deletions and inversions occurred with an
average frequency of 53% and 57% for the NoAT and
AT group, respectively. We did not detect a statisti-
cally significant difference between the NoAT and AT
groups suggesting that treatment of zygotes with
acidic Tyrode’s solution does neither increase nor
decrease the efficiency of zygote electroporation
under our experimental conditions (Fig. 3 and
Table 2).
Discussion
In our study we developed a method for small volume
zygote electroporation of Cas12a-crRNA RNPs and
demonstrate its use for generating large gene dele-
tions. Outbred CD1 embryos were used for zygote
production in this study. However, further experi-
ments in the inbred C57BL6/J background showed
that founder mice with a homozygous Ubn1 deletion
were generated using the same conditions (Suppl.
Fig. 3). This observation demonstrates that the
efficiency of the procedure is not dependent on the
genetic background of the zygotes. The ability for
generating large deletions is desirable for the analysis
of genes that have not been extensively characterized
and for which critical sequences cannot be predicted
with reasonable certainty. Removal of a large part of
the coding exons or gene regulatory regions ensures
that a strong and potentially complete loss of function
mutation will be obtained. Nevertheless, generation of
large deletions might delete regulatory elements that
are not associated with the gene of interest and effects
on other genes might influence the resulting
% of zygotes
0
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100
survival 2-cell morula blastocyst ES cells deletions
intact zona
Ubn1
Ubn2
Rbm12
Total
acidic Tyrode’s
Ubn1
Ubn2
Rbm12
Total
Fig. 4 Efficiency of gene deletions by electroporation of
Cas12a RNP complexes into zygotes. Embryo development and
gene deletions were determined for zygotes that were used for
electroporation either with intact zona pellucida (black lines and
markers) or whose zona had been partially removed by
treatment with acidic Tyrode’s solution (orange line and
markers). Percentages are calculated relative to the number of
zygotes used for the experiment and plotted for each gene
(markers) and combined for all 3 genes (lines). (Color
figure online)
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phenotype. Often specific antisera are unavailable for
genes that have not been studied and, hence, indepen-
dent confirmation of the absence of a protein product is
not an experimental possibility. Generating deletions
is thought to be considerably more difficult than
obtaining indel mutations as it requires the simulta-
neous cleavage at two sites and a fortuitous DNA
repair event that joins the flanking sequences. We
obtained a small number of ESC lines that neither
yielded expected PCR products for a deletion, an
inversion, nor a wildtype allele (Fig. 3, samples
marked with genotype ?/?). This observation is likely
explained by larger rearrangements of the gene locus
that has been previously reported to accompany
CRISPR-mediated genetic engineering (Boroviak
et al. 2017; Kosicki et al. 2018; Shin et al. 2017) and
can include unpredicted larger deletions (Owens et al.
2019) leading to a loss of primer binding sites.
Moreover, we observed two clones that showed two
wildtype 30 PCR products, one that showed two
wildtype 50 PCR products, and three clones that
showed lower weight wildtype 50 PCR products
(Fig. 3; lanes marked with *, ** and ***), which
could be results of smaller rearrangements. However,
in these cases we cannot fully rule out the possibility of
polyclonal ESC lines. Using a method with small
electroporation volumes and two Cas12a-crRNA
RNPs at high concentration, we were able to generate
10, 17, and 13 kb long deletions in Ubn1, Ubn2, and
Rbm12, respectively. The overall frequency of dele-
tions that was observed in our experiments was 56%,
55%, and 21% for Ubn1, Ubn2, and Rbm12, respec-
tively. This observation suggests that the high con-
centration of Cas12a RNP nuclease pairs used in our
experiments are favorable for generating deletions.
Cas12a can be a relevant alternative to Cas9 for
engineering the mouse genome. In our experiments the
use of shorter synthetic Cas12a crRNA guides is cost
effective and simplifies project setup by using reagents
of a standardized quality. In our experience the vast
majority of assembled Cas12a RNP nucleases showed
specific nuclease activity in in vitro cleavage reactions
using plasmids or PCR products as templates (Kissling
et al. 2019). The ability to test the activity of Cas12a
RNPs in vitro is important for ensuring that experi-
ments that involve laboratory animals are carried out
under optimal conditions. Recently, Cas12a protein
has become available from commercial suppliers
facilitating the use of Cas12a RNP complexes in a
wider range of laboratories. In our study we present an
efficient method that (1) minimizes reagents by
electroporation in a small volume, (2) takes advantage
of the synthetic short Cas12a crRNAs, and (3) avoids
partial zona removal for improving consistency and
minimizing embryo loss. From our data we estimate
that at least one gene deletion can be expected when
using as few as 10 zygotes (Fig. 4). The high
efficiency and rapid setup suggest potential of elec-
troporation for engineering deletions in species for
which limited numbers of zygotes are available or for
large scale genomics initiatives that aim at systematic
screening a larger number of genes.
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